PEMETREXED , KEYTRUDA 25 mg/mL concentrate for solution for infusion, PACLITAXEL ALBUMIN-BOUND, CARBOPLATIN , PACLITAXEL , pembrolizumab, CISPLATIN
MK-3475-A86
Phase 3 small_molecule active
Quick answer
PEMETREXED , KEYTRUDA 25 mg/mL concentrate for solution for infusion, PACLITAXEL ALBUMIN-BOUND, CARBOPLATIN , PACLITAXEL , pembrolizumab, CISPLATIN for Metastatic (stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC). is a Phase 3 program (small_molecule) at Merck Sharp and Dohme with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Merck Sharp and Dohme
- Indication
- Metastatic (stage IV) squamous or nonsquamous non-small cell lung cancer (NSCLC).
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active